Viewing Study NCT04535908



Ignite Creation Date: 2024-05-06 @ 3:08 PM
Last Modification Date: 2024-10-26 @ 1:43 PM
Study NCT ID: NCT04535908
Status: TERMINATED
Last Update Posted: 2022-10-03
First Post: 2020-08-25

Brief Title: Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older
Sponsor: Medical University of Graz
Organization: Medical University of Graz

Study Overview

Official Title: Clinical Study to Evaluate Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older
Status: TERMINATED
Status Verified Date: 2022-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Treatment standard has changed
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The majority of all new prostate cancer cases are diagnosed in men aged 70 years with the highest incidence in men aged 90 years Management options for localized prostate cancer include active surveillance in patients with low-risk disease radical prostatectomy or external beam radiation therapy

In previous studies hypofractionated prostate cancer irradiation regimens have been shown to represent a highly effective treatment option for prostate cancer However patients aged 75 years or older were underrepresented in most trials resulting in the lack of a robust evidence base

The proposed study will evaluate radiation-induced toxicity as well as outcome after hypofractionated external beam radiotherapy in prostate cancer patients aged 75 years or older
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None